215 related articles for article (PubMed ID: 10913511)
1. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
Winokur A; Sateia MJ; Hayes JB; Bayles-Dazet W; MacDonald MM; Gary KA
Biol Psychiatry; 2000 Jul; 48(1):75-8. PubMed ID: 10913511
[TBL] [Abstract][Full Text] [Related]
2. Effects of mirtazapine on sleep polygraphic variables in major depression.
Schittecatte M; Dumont F; Machowski R; Cornil C; Lavergne F; Wilmotte J
Neuropsychobiology; 2002; 46(4):197-201. PubMed ID: 12566938
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
4. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
Shen J; Chung SA; Kayumov L; Moller H; Hossain N; Wang X; Deb P; Sun F; Huang X; Novak M; Appleton D; Shapiro CM
Can J Psychiatry; 2006 Jan; 51(1):27-34. PubMed ID: 16491981
[TBL] [Abstract][Full Text] [Related]
5. Influence of mirtazapine on salivary cortisol in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Radhakishun FS; van den Bos J; van der Heijden BC; Roes KC; O'Hanlon JF
J Clin Psychopharmacol; 2000 Oct; 20(5):531-7. PubMed ID: 11001237
[TBL] [Abstract][Full Text] [Related]
8. The effects of mirtazapine on sleep in patients with major depressive disorder.
Dolder CR; Nelson MH; Iler CA
Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine in major depression with comorbid generalized anxiety disorder.
Goodnick PJ; Puig A; DeVane CL; Freund BV
J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
[TBL] [Abstract][Full Text] [Related]
10. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
13. [Mirtazapine--pharmacologic action and clinical advantages].
Rihmer Z; Purebl G
Neuropsychopharmacol Hung; 2009 Mar; 11(1):35-40. PubMed ID: 19731817
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant treatment of the depressed patient with insomnia.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 17():28-31; discussion 46-8. PubMed ID: 10446739
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
Cankurtaran ES; Ozalp E; Soygur H; Akbiyik DI; Turhan L; Alkis N
Support Care Cancer; 2008 Nov; 16(11):1291-8. PubMed ID: 18299900
[TBL] [Abstract][Full Text] [Related]
16. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
Wang D; Li Z; Li L; Hao W
Asia Pac Psychiatry; 2014 Jun; 6(2):152-60. PubMed ID: 23857869
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Nutt DJ
Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]